Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines

Rong Huang, Daryl J Murry, Dhanashri Kolwankar, Stephen D. Hall, David R. Foster

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The increased expression of drug transporters following cancer chemotherapy contributes to resistance. This may reflect transcriptional up-regulation and/or clonal selection. We quantified the expression of mRNA for ABCB1 (mdr1), ABCC1 (mrp1), ABCC2 (mrp2) and ABCC3 (mrp3) to evaluate the potential contribution of induction. ABCB1, ABCC1-3 mRNAs were quantified by real time RT-PCR and normalized to GAPDH. We used intestinal cells that express high pregnane X receptor (LS174T), low pregnane X receptor (Caco-2) and lung cells (A549) that express glucocorticoid receptor and low pregnane X receptor. Rifampin (10 μM) caused significant induction of ABCB1 (595 ± 263%, p < 0.05) in LS174T cells but induction was absent in Caco-2 or A549 cells. ABCC1 was not induced in any cell at 24, 48 and 72 h following rifampin treatment. In contrast, vincristine (10 nM and 100 nM), a ligand for ABCB1 and ABCC1-3 and a potential PXR/CAR ligand, induced ABCC2 and ABCC3 expression in LS174T cells at 48 h (372 ± 87% and 303 ± 42%, respectively, p < 0.05). A similar induction of ABCC2 and ABCC3 genes was also seen with 10 nM VCR in A549 cells following 48 h treatment. In summary, there may be a significant contribution of transcriptional activation to multi-drug resistance. However, this is cell selective and is not necessarily dependent on PXR mediated effects.

Original languageEnglish (US)
Pages (from-to)1695-1704
Number of pages10
JournalBiochemical Pharmacology
Volume71
Issue number12
DOIs
StatePublished - Jun 14 2006

Fingerprint

Drug and Narcotic Control
Vincristine
Cells
Rifampin
Carcinoma
Cell Line
Pharmaceutical Preparations
Caco-2 Cells
Videocassette recorders
Ligands
Messenger RNA
Chemotherapy
Glucocorticoid Receptors
Genes
Chemical activation
Multiple Drug Resistance
Transcriptional Activation
Real-Time Polymerase Chain Reaction
Up-Regulation
pregnane X receptor

Keywords

  • ABCB1
  • ABCC1
  • ABCC2
  • ABCC3
  • Transcriptional regulation
  • Vincristine

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. / Huang, Rong; Murry, Daryl J; Kolwankar, Dhanashri; Hall, Stephen D.; Foster, David R.

In: Biochemical Pharmacology, Vol. 71, No. 12, 14.06.2006, p. 1695-1704.

Research output: Contribution to journalArticle

Huang, Rong ; Murry, Daryl J ; Kolwankar, Dhanashri ; Hall, Stephen D. ; Foster, David R. / Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. In: Biochemical Pharmacology. 2006 ; Vol. 71, No. 12. pp. 1695-1704.
@article{121894cbe62e46519361e82c343a4c4b,
title = "Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines",
abstract = "The increased expression of drug transporters following cancer chemotherapy contributes to resistance. This may reflect transcriptional up-regulation and/or clonal selection. We quantified the expression of mRNA for ABCB1 (mdr1), ABCC1 (mrp1), ABCC2 (mrp2) and ABCC3 (mrp3) to evaluate the potential contribution of induction. ABCB1, ABCC1-3 mRNAs were quantified by real time RT-PCR and normalized to GAPDH. We used intestinal cells that express high pregnane X receptor (LS174T), low pregnane X receptor (Caco-2) and lung cells (A549) that express glucocorticoid receptor and low pregnane X receptor. Rifampin (10 μM) caused significant induction of ABCB1 (595 ± 263{\%}, p < 0.05) in LS174T cells but induction was absent in Caco-2 or A549 cells. ABCC1 was not induced in any cell at 24, 48 and 72 h following rifampin treatment. In contrast, vincristine (10 nM and 100 nM), a ligand for ABCB1 and ABCC1-3 and a potential PXR/CAR ligand, induced ABCC2 and ABCC3 expression in LS174T cells at 48 h (372 ± 87{\%} and 303 ± 42{\%}, respectively, p < 0.05). A similar induction of ABCC2 and ABCC3 genes was also seen with 10 nM VCR in A549 cells following 48 h treatment. In summary, there may be a significant contribution of transcriptional activation to multi-drug resistance. However, this is cell selective and is not necessarily dependent on PXR mediated effects.",
keywords = "ABCB1, ABCC1, ABCC2, ABCC3, Transcriptional regulation, Vincristine",
author = "Rong Huang and Murry, {Daryl J} and Dhanashri Kolwankar and Hall, {Stephen D.} and Foster, {David R.}",
year = "2006",
month = "6",
day = "14",
doi = "10.1016/j.bcp.2006.03.009",
language = "English (US)",
volume = "71",
pages = "1695--1704",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines

AU - Huang, Rong

AU - Murry, Daryl J

AU - Kolwankar, Dhanashri

AU - Hall, Stephen D.

AU - Foster, David R.

PY - 2006/6/14

Y1 - 2006/6/14

N2 - The increased expression of drug transporters following cancer chemotherapy contributes to resistance. This may reflect transcriptional up-regulation and/or clonal selection. We quantified the expression of mRNA for ABCB1 (mdr1), ABCC1 (mrp1), ABCC2 (mrp2) and ABCC3 (mrp3) to evaluate the potential contribution of induction. ABCB1, ABCC1-3 mRNAs were quantified by real time RT-PCR and normalized to GAPDH. We used intestinal cells that express high pregnane X receptor (LS174T), low pregnane X receptor (Caco-2) and lung cells (A549) that express glucocorticoid receptor and low pregnane X receptor. Rifampin (10 μM) caused significant induction of ABCB1 (595 ± 263%, p < 0.05) in LS174T cells but induction was absent in Caco-2 or A549 cells. ABCC1 was not induced in any cell at 24, 48 and 72 h following rifampin treatment. In contrast, vincristine (10 nM and 100 nM), a ligand for ABCB1 and ABCC1-3 and a potential PXR/CAR ligand, induced ABCC2 and ABCC3 expression in LS174T cells at 48 h (372 ± 87% and 303 ± 42%, respectively, p < 0.05). A similar induction of ABCC2 and ABCC3 genes was also seen with 10 nM VCR in A549 cells following 48 h treatment. In summary, there may be a significant contribution of transcriptional activation to multi-drug resistance. However, this is cell selective and is not necessarily dependent on PXR mediated effects.

AB - The increased expression of drug transporters following cancer chemotherapy contributes to resistance. This may reflect transcriptional up-regulation and/or clonal selection. We quantified the expression of mRNA for ABCB1 (mdr1), ABCC1 (mrp1), ABCC2 (mrp2) and ABCC3 (mrp3) to evaluate the potential contribution of induction. ABCB1, ABCC1-3 mRNAs were quantified by real time RT-PCR and normalized to GAPDH. We used intestinal cells that express high pregnane X receptor (LS174T), low pregnane X receptor (Caco-2) and lung cells (A549) that express glucocorticoid receptor and low pregnane X receptor. Rifampin (10 μM) caused significant induction of ABCB1 (595 ± 263%, p < 0.05) in LS174T cells but induction was absent in Caco-2 or A549 cells. ABCC1 was not induced in any cell at 24, 48 and 72 h following rifampin treatment. In contrast, vincristine (10 nM and 100 nM), a ligand for ABCB1 and ABCC1-3 and a potential PXR/CAR ligand, induced ABCC2 and ABCC3 expression in LS174T cells at 48 h (372 ± 87% and 303 ± 42%, respectively, p < 0.05). A similar induction of ABCC2 and ABCC3 genes was also seen with 10 nM VCR in A549 cells following 48 h treatment. In summary, there may be a significant contribution of transcriptional activation to multi-drug resistance. However, this is cell selective and is not necessarily dependent on PXR mediated effects.

KW - ABCB1

KW - ABCC1

KW - ABCC2

KW - ABCC3

KW - Transcriptional regulation

KW - Vincristine

UR - http://www.scopus.com/inward/record.url?scp=33646497418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646497418&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2006.03.009

DO - 10.1016/j.bcp.2006.03.009

M3 - Article

VL - 71

SP - 1695

EP - 1704

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -